Challenge IM is dedicated to biopharmaceutical membrane filtration solutions

Challenge IM integrates R&D, manufacturing, sales, and technical services to deliver a highly efficient, globally connected operating platform. Our core portfolio includes advanced, highly automated filtration systems and a comprehensive range of high-performance membrane filtration consumables. These solutions are extensively deployed across critical process steps throughout the biopharmaceutical value chain, supporting applications in monoclonal antibodies and ADCs, CGT, vaccines, nucleic acid therapeutics, recombinant proteins, blood products, exosomes, and IVD.
Challenge IM’s proprietary fully automated, unattended tangential flow filtration (TFF) system addresses an unmet need in the global market and continues to set new benchmarks for process efficiency and technological innovation.